Why Constellation®?
Discover why developers trust Constellation with their cell therapy manufacturing scale-up.
Designed to address every manufacturing challenge.
Automate your cell therapy manufacturing with confidence and achieve greater throughput, consistency, and operational efficiency at lower costs.
Your biology protected.
Protecting biological performance is fundamental to the Constellation system. The platform is designed to operate your exact manufacturing process, cell processing workflow, bioprocessing instruments and consumables. This enables a clear, compliant path to cell therapy scale-up.
Return on investment in less than 12 months.
Independent modelling by PM Group, presented at Interphex 2025, shows that Constellation delivers packback in around 11 months. The investment required pays for itself quickly by establishing efficient manufacturing operations from day one.
Manufacturing that grows with you.
Instead of locking you into fixed infrastructure, Constellation uses configurable, modular workstations for an architecture that expands with your manufacturing needs.
Unparalleled operational reliability.
Production doesn’t stop when issues arise. If a tool or robot is offline, the system re-routes workflows automatically in real-time and teams can service or replace equipment while the rest of the system keeps running – mobile robots move around them.
The result is a uniquely reliable system designed with redundancy to protect batches.
Expert manufacturing partnership.
Whether you're in development or manufacturing today, we provide a practical, phased and low-risk route to automation. We partner with your team to build a roadmap that aligns with your clinical progress, commercial strategy and manufacturing goals.
Choosing your cell therapy manufacturing approach.
How can manufacturing be scaled without compromising quality or control? Several approaches are available, each offering different trade-offs in throughput, cost, and long-term scalability.
Constellation vs pod automation.
Compared to pod-based manufacturing solutions, Constellation uniquely allows for:
- Flexible facility layouts that evolve with changing manufacturing needs
- Whole-system coordination through a unified software layer
- Dynamic workflow re-routing to maintain production during maintenance
- Different therapies and process variants within the same system
- Greater operational resilience with no single point of failure
- Lower long-term infrastructure and expansion costs
Manufacturing that grows with you.
Instead of locking you into fixed infrastructure, Constellation uses configurable, modular workstations for an architecture that expands with your manufacturing needs.
Add capacity as and where you need, without duplicating infrastructure. Upgrade technologies as your manufacturing evolves. Reconfigure your system without disrupting operations.
The process you've perfected, at the scale you need.
Protecting biological performance is fundamental to the Constellation system. The platform is designed to operate your exact manufacturing process, cell processing workflow, bioprocessing instruments and consumables. By integrating GMP instruments such as the Sefia Select™, Cue® and G-Rex® into a single coordinated platform, Constellation enables a clear, compliant path to cell therapy scale-up.
Return on investment in less than 12 months.
Constellation® is a capital investment that pays for itself quickly by establishing efficient manufacturing operations from day one. Independent modelling by PM Group, presented at Interphex 2025, shows that Constellation delivers packback in around 11 months.
This graph compares the estimated annual operating costs (OPEX) of different cell therapy manufacturing approaches.
Unparalleled operational reliability.
Production doesn’t stop when issues arise. If a tool or robot is offline, the system re-routes workflows automatically in real-time and teams can service or replace equipment while the rest of the system keeps running – mobile robots move around them.
The result is a uniquely reliable system designed with redundancy to protect batches and support 24/7 continuous cell therapy manufacturing.
An expert partner for your manufacturing strategy.
Whether you're in clinical development, preparing for approval, or manufacturing manually today, we provide a practical, phased and low-risk route to automation. We partner with your team to build a roadmap that aligns with your clinical progress, commercial strategy, and manufacturing goals.
Start where it makes sense. Expand when the time is right.
Ready to explore your
cell therapy scale-up?
We’ll be in touch to arrange a discovery call or in-person visit.